home / stock / mcujf / mcujf news

MCUJF News and Press, Medicure Inc

Stock Information
Company Name: Medicure Inc
Stock Symbol: MCUJF
Market: OTC
Website: medicure.com
Menu
MCUJF MCUJF Quote MCUJF Short MCUJF News MCUJF Articles MCUJF Message Board
Get MCUJF Alerts

News, Short Squeeze, Breakout and More Instantly...
MCUJF - Medicure to acquire intellectual property from CanAm Bioresearch

2024-06-25 06:08:14 ET More on Medicure Financial information for Medicure Read the full article on Seeking Alpha For further details see: Medicure to acquire intellectual property from CanAm Bioresearch
MCUJF - Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property

WINNIPEG, MB / ACCESSWIRE / June 24, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announces ...

MCUJF - Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results

WINNIPEG, MB / ACCESSWIRE / May 28, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported it...

MCUJF - Expected US Company Earnings on Friday, May 24th, 2024

Toto Ltd ADR (TOTDY) is expected to report for Q4 2024 NSK Ltd. ADR (NPSKY) is expected to report for Q4 2024 Monarch Cement Co. (MCEM) is expected to report for Q1 2024 HST Global Inc (HSTC) is expected to report for Q1 2024 Sumitomo Heavy Industries Ltd. ADR (SOHVY) is expected ...
MCUJF - Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency

WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announced today...

MCUJF - Medicure GAAP EPS of -$0.09, revenue of $21.7M

2024-04-09 11:01:31 ET More on Medicure Financial information for Medicure Read the full article on Seeking Alpha For further details see: Medicure GAAP EPS of -$0.09, revenue of $21.7M

MCUJF - Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023

WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTCPINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported it...
MCUJF - Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023

WINNIPEG, MB / ACCESSWIRE / April 4, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the...

MCUJF - Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes

WINNIPEG, MB / ACCESSWIRE / December 5, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, through its pharm...

MCUJF - Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease

WINNIPEG, MB / ACCESSWIRE / November 23, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announ...
Next 10